Thrombosis after mitral valvuloplasty: A review of two cases and the role of antithrombotic therapy

SummaryWe describe two cases of thrombosis after mitral valvuloplasty (MV). Antithrombotic therapy after MV in patients with no thromboembolic risk factors is essentially based on treatment with a platelet aggregation inhibitor. This strategy may not be sufficient in some cases and the introduction of oral anticoagulant therapy may be necessary.